S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor

NCT00068367 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

NETWORK

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: erlotinib hydrochloride

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]